Upcoming Webinars

Missed a Session?

Catch up anytime — previous webinars in this series are available on our On-Demand page.

Advancements in Microwave Ablation Series (Part 1): Early Experience and Case Review of the IntelliBlate Microwave System

Tuesday, 18 November 2025 | 7 - 8:30 p.m. ET

Microwave ablation is advancing rapidly in interventional oncology. This webinar will review the latest techniques, showcase real-world experiences, and discuss how new innovations are enhancing precision, efficiency, and patient outcomes.

Faculty

Kirema Garcia-Reyes, MD

Mount Sinai Health System

Brian T. Welch, MD

Mayo Clinic

Register Now

This webinar is sponsored by:

Bone Club Series

Join SIO for an intermediate-level (200) musculoskeletal (MSK) three-part webinar series. Part one will focus on the interventional treatment of malignant and metastatic bone lesions in both the axial and appendicular skeleton, covering techniques like ablation, cementation, and embolization. Part two will focus on the finer details of patient evaluation and procedural techniques for benign bone lesions, demonstrating bone grafting for UBC/ABC. Part three addresses the general guidelines and physiology for the management of oncologic pain using cryoneurolysis, techniques for managing chest wall masses and ablative options for management of aggressive pelvic disease tumors.

To get the most out of the series, we recommend registering for all three sessions. Soon after a session has been completed, they will be made available on the on-demand webinars page.

Part 3: How I Do It—From Imaging Workup to Intervention: Cryoneurolysis for Pain

Tuesday, 11 November 2025 | 7 – 8:30 p.m. ET

Faculty

Moderator

Sirish Kishore, MD

Stanford University

Faculty Panel

Junjian Huang, MD

Emory Healthcare

Shantanu Warhadpande MD

University of Michigan

John David Prologo, MD

Emory Healthcare

Register Now

Bone Club is supported by:

HCC Webinar Series

Join SIO for a three-part webinar series on hepatocellular carcinoma (HCC) this fall. Part one will cover advances in treatment with a shift toward combination therapies and sequencing strategies to optimize patient outcomes. Part two will explore the role of immunotherapy in HCC, including combinations with locoregional therapies, mechanisms of resistance, biomarker predictions and other therapeutic targets. Part three will highlight ongoing critical trials of combination locoregional therapy and immunotherapy in the liver.

To get the most out of the series, we recommend registering for all three sessions. Soon after a session has been completed, they will be made available on the on-demand webinars page.

Part 2: Integrating Immunotherapy with Locoregional Therapies in HCC: Mechanisms, Biomarkers, and Resistance

Wednesday, 22 October 2025 | 7 – 8 p.m. ET

Faculty

Moderator

Julius Chapiro, MD, PhD

Yale University

Faculty Panel

Terence Gade, MD, PhD

University of Pennsylvania

Sarah Manes, MS

Global Liver Institute

Anjana Pillai, MD

University of Chicago

Michael Soulen, MD, FSIR, FCIRSE

University of Pennsylvania

Register Now

Part 3: Ongoing Critical Trials of Combination Locoregional Therapy and Immunotherapy in the Liver

Tuesday, 4 November 2025 | 7 – 8:30 p.m. ET

This webinar is sponsored by:

Faculty

Moderator

Zach Berman, MD

UC San Diego

Faculty Panel

Adam Burgoyne, MD, PhD

UC San Diego

Kirema Garcia-Reyes, MD

Mount Sinai

Christopher Malone, MD

Washington University

Register Now

This webinar series is sponsored by:

Targeting Tumors from Within: Intratumoral Therapies and Team-Based Care in Metastatic Melanoma

Postponed: Stay tuned for more details

Join us for an engaging webinar titled “Targeting Tumors from Within: Intratumoral Therapies and Team-Based Care in Metastatic Melanoma,” sponsored by Replimune and Johnson & Johnson. This session will explore the evolving treatment landscape for advanced melanoma, with a particular focus on patients who have progressed on PD-1 inhibitors. Attendees will gain valuable insights into second-line treatment strategies, including the role of oncolytic immunotherapies.

Faculty

Rahul Sheth, MD, FSIR

MD Anderson Cancer Center

Michael Wong, MD, PhD, FRCPC

Roswell Park Comprehensive Cancer Center

This webinar is sponsored by: